-$140,000
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Leonard Braden MichaelAug 5, 2024Buy206,025$1.2443$260,000
Leonard Braden MichaelAug 2, 2024Buy167,544$1.2916$220,000
Leonard Braden MichaelJul 31, 2024Buy100,000$1.3264$130,000
Leonard Braden MichaelJul 30, 2024Buy173,730$1.303$230,000
Leonard Braden MichaelJul 22, 2024Buy17,716$1.3297$24,000
Leonard Braden MichaelJul 19, 2024Buy6,689$1.3$8,700
Leonard Braden MichaelJul 18, 2024Buy130,317$1.3011$170,000
Leonard Braden MichaelJul 5, 2024Buy123,017$1.1489$140,000
Leonard Braden MichaelJul 3, 2024Buy143,288$1.159$170,000
Leonard Braden MichaelJul 2, 2024Buy86,092$1.144$98,000
Leonard Braden MichaelJul 1, 2024Buy107,434$1.1373$120,000
Leonard Braden MichaelJun 28, 2024Buy801,000$1.1193$900,000
Leonard Braden MichaelJun 28, 2024Buy400,000$1.13$450,000
Leonard Braden MichaelJun 27, 2024Buy235,000$1.1546$270,000
Leonard Braden MichaelJun 18, 2024Buy50,000$1.1301$57,000
Leonard Braden MichaelJun 17, 2024Buy150,000$1.13$170,000
Leonard Braden MichaelJun 14, 2024Buy345,000$1.1658$400,000
Leonard Braden MichaelJun 13, 2024Buy500,000$1.15$580,000
Leonard Braden MichaelJun 13, 2024Buy28,621$1.1445$33,000
Leonard Braden MichaelJun 12, 2024Buy82,579$1.14$94,000
Leonard Braden MichaelJun 11, 2024Buy1,000,000$1.08$1.1M
Powell Andrew Kenneth WilliamMar 4, 2024Buy6,000$1.25$7,500
Powell Andrew Kenneth WilliamMar 1, 2024Buy8,500$1.23$10,000
Monahan JosephOct 23, 2023Sell6,000$5.0767$30,000
Balthaser KevinSep 6, 2023Buy9,490$7.9$75,000
Loerop JamesAug 28, 2023Buy14,705$6.7976$100,000
Monahan JosephAug 21, 2023Sell6,000$7.3158$44,000
Monahan JosephJun 20, 2023Sell6,000$10.2771$62,000
Manion Douglas J.Mar 17, 2023Buy6,300$7.8623$50,000
Manion Douglas J.Mar 9, 2023Buy6,500$7.735$50,000
Walker NealMar 3, 2023Sell30,240$12.6346$380,000
Monahan JosephMar 3, 2023Sell16,037$12.6342$200,000
Balthaser KevinMar 3, 2023Sell894$12.6281$11,000
Walker NealMar 2, 2023Sell29,000$12.3651$360,000
Monahan JosephMar 2, 2023Sell14,800$12.3665$180,000
Balthaser KevinMar 2, 2023Sell1,000$12.289$12,000
Monahan JosephFeb 15, 2023Sell5,000$13.0621$65,000
Loerop JamesFeb 8, 2023Sell4,267$13.8909$59,000
Walker NealFeb 2, 2023Sell3,121$16.8827$53,000
Walker NealFeb 2, 2023Sell1,079$14.5671$16,000
Walker NealFeb 2, 2023Sell600$15.5533$9,300
Walker NealFeb 2, 2023Sell200$17.535$3,500
Walker NealFeb 1, 2023Sell25,000$16.747$420,000
Walker NealJan 4, 2023Sell15,000$14.8895$220,000
Walker NealJan 3, 2023Sell23,382$15.1855$360,000
Walker NealJan 3, 2023Sell1,618$16.1594$26,000
Monahan JosephDec 15, 2022Sell5,000$15.8823$79,000
SCHIFF ANDREW NNov 14, 2022Sell1,371$17.08$23,000
SCHIFF ANDREW NNov 11, 2022Sell41,160$17.0597$700,000
SCHIFF ANDREW NNov 10, 2022Sell11,395$17.0246$190,000
SCHIFF ANDREW NOct 26, 2022Sell14,540$17.005$250,000
SCHIFF ANDREW NOct 25, 2022Sell12,018$17.0175$200,000
SCHIFF ANDREW NOct 24, 2022Sell14,616$17.0078$250,000
SCHIFF ANDREW NOct 18, 2022Sell32,093$16.8891$540,000
SCHIFF ANDREW NOct 17, 2022Sell19,944$16.0493$320,000
Monahan JosephOct 17, 2022Sell5,000$15.9815$80,000
SCHIFF ANDREW NOct 7, 2022Sell7,324$16.1591$120,000
SCHIFF ANDREW NOct 6, 2022Sell37,839$16.537$630,000
SCHIFF ANDREW NOct 4, 2022Sell7,700$16.0076$120,000

What's the latest insider transaction for Aclaris Therapeutics?

The most recent insider transaction for Aclaris Therapeutics was conducted by Leonard Braden Michael, who sold 206,025 shares on August 5, 2024 at a price of $1.24 per share.

Which insider bought the most ACRS stock over the last two years?

Leonard Braden Michael has bought the most ACRS stock in the last 2 years, with a total value of $5.6M.

Which insider has sold the most ACRS stock over the last two years?

SCHIFF ANDREW N has sold the most ACRS stock in the last 2 years, with a total value of $3.3M.

What is the total value of insider transactions for Aclaris Therapeutics (ACRS) in the last 2 years?

The total value of insider transactions for Aclaris Therapeutics in the last 2 years is negative, amounting to -$140,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Aclaris Therapeutics' market confidence?

Over the last 2 years, insider transactions for Aclaris Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.